Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
BACKGROUND: The development of a safe and effective vaccine against the human immunodeficiency virus type 1 (HIV-1) is critical to pandemic control. METHODS: In a community-based, randomized, multicenter, double-blind, placebo-controlled efficacy trial, we evaluated four priming injections of a reco...
Saved in:
Main Authors: | Supachai Rerks-Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, Jaranit Kaewkungwal, Joseph Chiu, Robert Paris, Nakorn Premsri, Chawetsan Namwat, Mark De Souza, Elizabeth Adams, Michael Benenson, Sanjay Gurunathan, Jim Tartaglia, John G. McNeil, Donald P. Francis, Donald Stablein, Deborah L. Birx, Supamit Chunsuttiwat, Chirasak Khamboonruang, Prasert Thongcharoen, Merlin L. Robb, Nelson L. Michael, Prayura Kunasol, Jerome H. Kim |
---|---|
Other Authors: | Thailand Ministry of Public Health |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/27795 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: A post-hoc analysis of the Thai phase 3 efficacy trial RV 144
by: Merlin L. Robb, et al.
Published: (2018) -
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E
by: Supachai Rerks-Ngarm, et al.
Published: (2018) -
P15-14. Assuring data quality of the phase III vaccine trial of ALVAC vaccine priming and AIDSVAX vaccine boosting in Thailand
by: J. Kaewkungwal, et al.
Published: (2018) -
Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand
by: Punnee Pitisuttithum, et al.
Published: (2018) -
Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand
by: Chitraporn Karnasuta, et al.
Published: (2018)